INVO Fertility (NASDAQ:IVF) Stock Price Down 0.7% – Should You Sell?

INVO Fertility, Inc (NASDAQ:IVF)’s share price dropped 0.7% during trading on Friday . The company traded as low as $1.39 and last traded at $1.48. Approximately 44,432 shares changed hands during mid-day trading, a decline of 94% from the average daily volume of 796,319 shares. The stock had previously closed at $1.49.

Analyst Ratings Changes

IVF has been the subject of a number of research analyst reports. Wall Street Zen raised INVO Fertility from a “sell” rating to a “hold” rating in a research report on Saturday, March 7th. Weiss Ratings raised INVO Fertility from a “sell (e)” rating to a “sell (e+)” rating in a research report on Wednesday, May 6th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, INVO Fertility has an average rating of “Moderate Buy” and a consensus price target of $20.00.

INVO Fertility Price Performance

The company has a current ratio of 0.27, a quick ratio of 0.25 and a debt-to-equity ratio of 0.15. The business has a fifty day simple moving average of $1.83 and a 200 day simple moving average of $4.17. The stock has a market capitalization of $2.64 million, a P/E ratio of 0.00 and a beta of 2.33.

INVO Fertility (NASDAQ:IVF) last issued its quarterly earnings data on Tuesday, June 2nd. The company reported $472.78 EPS for the quarter. The company had revenue of $1.60 million for the quarter.

Institutional Trading of INVO Fertility

An institutional investor recently bought a new position in INVO Fertility stock. Armistice Capital LLC acquired a new position in shares of INVO Fertility, Inc (NASDAQ:IVF) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 207,644 shares of the company’s stock, valued at approximately $156,000. Armistice Capital LLC owned approximately 8.69% of INVO Fertility as of its most recent filing with the Securities and Exchange Commission. 12.02% of the stock is owned by institutional investors and hedge funds.

INVO Fertility Company Profile

INVO Fertility (NASDAQ:IVF) is a medical technology company focused on advancing assisted reproductive treatments through innovative in-vivo incubation solutions. The company develops and commercializes devices designed to facilitate fertilization and early embryo development inside a patient’s body, offering an alternative to conventional laboratory-based in vitro fertilization (IVF) techniques.

The company’s flagship product, the INVOcell device, is a single-use, intravaginal incubator that holds a controlled microenvironment for egg and sperm co-incubation.